SmartTab Featured on Medical Device and Diagnostics Industry as Emerging IBD Technology
By Sacha Heppell - May 25, 2021
In honor of World IBD Day, Chief Technology Officer, Doug Miller, PhD, sat down with Medical Device & Diagnostic Industry to share how we are working to change the game for diagnosing and treating Inflammatory Bowel Disease (IBD) with our ingestible technologies. World IBD Day is a time to come together worldwide in the fight against Crohn's disease and ulcerative colitis. We heard stories from patients around the world and their voice is fueling our mission and driving our innovations to transform IBD treatment.
The article features the SmartTab platform technology (TargetTab™, InjectTab™ and MultiTab™) and the companies plans for commercializing with Crohn's being the initial indication. Learn more about the smart wireless ingestible capsules intended to transform IBD treatment by making drug delivery more effective.
Medical Device + Diagnostic Industry (MD+DI) is a resource exclusively for original equipment manufacturers of medical devices and in vitro diagnostic products. The goal of MD+DI is to help industry professionals develop, design, and manufacture medical products that comply with complex and demanding regulations and market requirements.
Based in Denver, Colorado, SmartTab is engaged in the design, development and validation of next generation wireless drug delivery systems. The SmartTab technology platform is a personalized wireless solution comprised of an ingestible capsule with a microprocessor, smart polymer actuator, and active ingredients. SmartTab is on a mission to provide novel effective therapies to improve patient outcomes and compliance.